Nifedipine Market Analysis and In-depth Research on Market Size, Trends, Emerging Growth Factors and Regional Forecasts to 2023

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. Nifedipine is used specifically to treat hypertension, arrhythmias, and angina. In addition, it has several other therapeutical applications such as ryanoids syndrome, cephalagra, and others.

Factors such as increase in geriatric population, healthcare expenditure, incidence of chronic diseases such as heart failure, arrhythmias, & hypertension, and healthcare awareness fuel the growth of the market. However, stringent government regulations and side-effects of the drugs such as hypotension, gastric ulcers, and congestive heart failure hinder the market growth. Ongoing R&D activities are anticipated to present new growth opportunities.

Get sample copy of this report :
https://www.alliedmarketresearch.com/request-toc-and-sample/4003?utm_source=PC_OPR

Key Benefits:

• The study provides an in-depth analysis of the nifedipine market, with current trends and future estimations to elucidate investment pockets.

• Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.

• The report provides a quantitative analysis to help stakeholders to capitalize on prevailing market opportunities from 20172023 in terms of value.

• Extensive analysis of different segments helps understand various products of the market.

• Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

The market is segmented on the basis of product, application, and region. By product, the market is bifurcated into nifedipine controlled release tablets and nifedipine extended release tablets. Based on application, the market is categorized into primary pulmonary hypertension, heart failure, ryanoids disease, cephalagra, bronchial asthma, and premature labor. By region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Buy now and get FREE One Month Knowledge Tree Subscription (valid till 30 Nov'18):https:https://www.alliedmarketresearch.com/checkout/213370?utm_source=PC_OPR

Top Industry Players :

• GlaxoSmithKline plc
• Novartis AG
• Merck & Co., Inc.
• Abbott Laboratories
• Boehringer Ingelheim GmbH
• AstraZeneca plc
• F. Hoffmann-La Roche AG
• Teva Pharmaceutical Industries Ltd.
• Vectura Group plc
• Pfizer Inc.

Analyst Review :

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/4003?utm_source=PC_OPR

Table of Content :

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 NIFEDIPINE , BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. NIFEDIPINE CONTROLLED RELEASE TABLETS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. NIFEDIPINE EXTENDED ACTION TABLETS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Get Access to Full summary of this report at :
https://www.alliedmarketresearch.com/nifedipine-market?utm_source=PC_OPR

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.